Clinical trials show Zepbound delivering up to 22.5% average body weight loss, compared to Wegovy's 14.9%, according to the Obesity Medicine Association
The move has left many US patients scrambling for alternative options
Retatrutide is considered a newer medication with potentially promising outcomes for weight loss and metabolic health due to its unique triple-agonist approach
Understanding them helps you control them
NADPH contributes to recycling in oxidized antioxidant systems involving glutathione, thioredoxins, glutaredoxins, and peroxiredoxins and maintains another reactive oxygen species (ROS)-detoxifying enzyme, catalase, in its active form, suggesting that the homeostatic level of G6PD-derived NADPH determines the rate of oxidative damage [8]
All of these work against tirzepatide